First quarter Adjusted
EBITDA1 of $327 million
Safely restarted the Burnaby Refinery and
returned to normal operations
Progressing $500
million of non-core asset dispositions
CALGARY,
AB, May 1, 2024 /PRNewswire/ - Parkland
Corporation ("Parkland", "we", the "Company", or "our") (TSX: PKI),
today announced its financial and operating results for the three
months ended March 31, 2024.
"The team continues to deliver on our strategy and optimize our
portfolio," said Bob Espey,
President and Chief Executive Officer. "We have identified more
than $400 million of non-core assets for disposition, many of
which have been sold or are in the advanced stages of negotiation.
This represents more than 80 percent of our $500 million target by the end of 2025."
"I have full confidence in our team's ability to execute our
operational plan that leverages our customer advantage and unique
supply benefits, despite headwinds in some of the markets where we
operate," added Espey. "We expect to deliver our 2024 Adjusted
EBITDA Guidance range of $1.95 to
$2.05 billion and see a clear
pathway to achieving a Leverage Ratio at the low end of our 2 to 3
times target range by the end of 2025."
Q1 2024 Highlights
- Adjusted EBITDA of $327 million,
a decrease of 17 percent as compared to the first quarter of 2023,
driven by an unplanned shutdown of the Burnaby Refinery, which
began as a result of extreme cold weather and was extended by
technical issues during the subsequent start-up. The Burnaby
Refinery safely returned to normal operations on March 29, 2024.
- Net loss of $5 million
($0.03 per share, basic), a decrease
of $82 million as compared to the
first quarter of 2023, and Adjusted earnings2 of
$43 million ($0.25 per share, basic), a decrease of
$71 million from the first quarter of
2023.
- TTM Available cash flow2 of $770 million, an increase of 23 percent from
2023, and TTM Cash generated from (used in) operating
activities3 of $1,683
million, consistent with 2023.
- TTM Available cash flow per share2 of $4.38, an increase of 16 percent from 2023, and
TTM Cash generated from (used in) operating activities per
share3 of $9.56, a
decrease of 7 percent from 2023.
- Leverage Ratio4 of 3.1 times (2.8
times at Q4 2023), reflecting the impact of the unplanned shutdown
of the Burnaby Refinery.
- Purchased for cancellation approximately 1.8 million common
shares for $82 million under our
normal course issuer bid ("NCIB") program in Q1 2024.
- Parkland's quarterly dividend increased from $0.34 to $0.35 per
common share, or $1.40 per common
share annualized, representing a 3 percent increase from the prior
year. Dividends are expected to be declared and paid on a quarterly
basis.
Q1 2024 Segment Highlights
- Canada delivered Adjusted
EBITDA of $191 million, up 14 percent
from Q1 2023 ($167 million). This
increase was primarily driven by stronger fuel unit margins,
partially offset by lower commercial volumes due to unseasonably
warm weather. Company same-store volume growth ("Company
SSVG"5) was 5.9 percent, demonstrating the improved
productivity of our company-owned network.
- International delivered Adjusted EBITDA of $149 million, down 19 percent from Q1 2023
($183 million). The decrease was
primarily driven by lower fuel unit margins and wholesale volumes
as compared to Q1 2023, partially offset by successful cost
controls.
- USA delivered Adjusted EBITDA
of $33 million, up 57 percent from Q1
2023 ($21 million). Performance
reflects ongoing integration efforts, including C-store
improvements and On the Run rebrands. Lower fuel unit margins and
volumes reflect broader industry trends.
- Refining reported an Adjusted EBITDA loss of $32 million, compared to Adjusted EBITDA of
$38 million in Q1 2023. Composite
utilization5 at the Burnaby Refinery was 20 percent,
reflecting the unplanned shutdown, compared to 34 percent in Q1
2023, reflecting a scheduled turnaround. During the quarter, we
accelerated maintenance and refining optimization work previously
scheduled for the third quarter of 2024. As a result, we expect to
enhance the Burnaby Refinery's utilization and profitability for
the remainder of the year.
- Parkland's total recordable injury frequency rate5
on a trailing-twelve-months basis was 1.07, compared to 0.97 at
March 31, 2023.
|
_______________________
|
1
|
Total of segments
measure. See "Total of Segments Measures" section of this news
release.
|
2
|
Non-GAAP financial
measure or non-GAAP financial ratio. See "Non-GAAP Financial
Measures and Ratios" section of this news release.
|
3
|
Supplementary financial
measure. See "Supplementary Financial Measures" section of this
news release.
|
4
|
Capital management
measure. See "Capital Management Measures" section of this news
release.
|
5
|
Non-financial measure.
See "Non-Financial Measures" section of this news
release.
|
Consolidated Financial Overview
($ millions, unless otherwise
noted)
|
Three months ended
March 31,
|
Financial
Summary
|
2024
|
2023
|
Sales and operating
revenue
|
6,939
|
8,156
|
Adjusted
EBITDA(1)
|
327
|
395
|
Canada(2)
|
191
|
167
|
International(2)
|
149
|
183
|
USA(2)
|
33
|
21
|
Refining(2)
|
(32)
|
38
|
Corporate(2)
|
(14)
|
(14)
|
Net earnings
(loss)
|
(5)
|
77
|
Net earnings (loss) per
share – basic ($ per share)
|
(0.03)
|
0.44
|
Net earnings (loss) per
share – diluted ($ per share)
|
(0.03)
|
0.43
|
Trailing-twelve-month
("TTM") Cash generated from (used in) operating
activities(3)
|
1,683
|
1,688
|
TTM Cash generated from
(used in) operating activities per share(3)
|
9.56
|
10.23
|
TTM available cash
flow(4)
|
770
|
625
|
TTM available cash flow
per share(4)
|
4.38
|
3.79
|
1
|
Total of segments
measure. See "Total of Segments Measures" section of this news
release.
|
2
|
Measure of segment
profit (loss). See "Total of Segments Measures" section of this
news release.
|
3
|
Supplementary financial
measure. See "Supplementary Financial Measures" section of this
news release.
|
4
|
Non-GAAP financial
measure or non-GAAP financial ratio. See "Non-GAAP Financial
Measures and Ratios" section of this news release.
|
Q1 2024 Conference Call and Webcast Details
Parkland will host a webcast and conference call on Thursday, May 2, 2024 at 6:30 am MT (8:30 am
ET) to discuss the results. To listen to the live webcast
and watch the presentation, please use the following link:
https://app.webinar.net/xr4dJn89YLk
Analysts and investors interested in participating in the
question and answer session of the conference call may do so by
calling 1-888-390-0546 (toll-free) (Conference ID: 10413873).
International participants may call 1-800-389-0704 (toll-free)
(Conference ID: 10413873).
Please connect and log in approximately 10 minutes before the
beginning of the call. The webcast will be available for replay two
hours after the conference call ends at the link above. It will
remain available for one year and will also be posted at
www.parkland.ca.
MD&A and Interim Condensed Consolidated Financial
Statements
The Management's Discussion and Analysis for the three months
ended March 31, 2024 (the "Q1 2024
MD&A") and Interim Condensed Consolidated Financial Statements
for the three months ended March 31,
2024 (the "2024 Interim Condensed Consolidated Financial
Statements") provide a detailed explanation of Parkland's operating
results for the three months ended March 31,
2024. An English version of these documents will be
available online at www.parkland.ca and the System for
Electronic Data Analysis and Retrieval + ("SEDAR+") after the
results are released by newswire under Parkland's profile at
www.sedarplus.ca. The French versions of the Q1 2024 MD&A and
the Q1 2024 Condensed Consolidated Financial Statements will be
posted to www.parkland.ca and SEDAR+ as soon as they become
available.
About Parkland Corporation
Parkland is an international fuel distributor, marketer, and
convenience retailer with operations in 26 countries across the
Americas. We serve over one million customers each day. Our retail
network meets the fuel and convenience needs of everyday consumers.
Our commercial operations provide businesses with industrial fuels
so that they can better serve their customers. In addition to
meeting our customers' needs for essential fuels, we provide a
range of choices to help them lower their environmental impact.
These include renewable fuels sourcing, manufacturing and blending,
carbon and renewables trading, solar power, and ultra-fast EV
charging. With approximately 4,000 retail and commercial locations
across Canada, the United States and the Caribbean region, we have developed supply,
distribution and trading capabilities to accelerate growth and
business performance.
Our strategy is focused on two pillars: our Customer Advantage
and our Supply Advantage. Through our Customer Advantage, we aim to
be the first choice of our customers, cultivating their loyalty
through proprietary brands, differentiated offers, our extensive
network, competitive pricing, reliable service, and our compelling
loyalty program. Our Supply Advantage is based on achieving the
lowest cost to serve among independent fuel marketers and
distributors in the hard-to-serve markets in which we operate,
through our well-positioned assets, significant scale, and deep
supply and logistics capabilities. Our business is underpinned by
our people and our values of safety, integrity, community and
respect, which are deeply embedded across our organization.
Forward-Looking Statements
Certain statements contained herein constitute forward-looking
information and statements (collectively, "forward-looking
statements"). When used in this news release, the words "expect",
"will", "could", "would", "believe", "continue", "pursue" and
similar expressions are intended to identify forward-looking
statements. In particular, this news release contains
forward-looking statements with respect to, among other things:
business strategies, objectives and initiatives; Parkland's 2024
Adjusted EBITDA Guidance range and goal of achieving a Leverage
Ratio at the low end of our 2-3x target range by the end of 2025;
Parkland's expectation to enhance the Burnaby Refinery's
utilization and profitability for the remainder of 2024; Parkland's
expectations regarding future dividend amounts, and timing and
frequency of payments; Parkland's portfolio optimization strategy
and target of completing $500 million
of non-core asset dispositions, and the timing in respect
thereof; and Parkland's plans to implement ongoing operating and
MG&A cost reductions.
These statements involve known and unknown risks, uncertainties
and other factors that may cause actual results or events to differ
materially from those anticipated in such forward-looking
statements. No assurance can be given that these expectations will
prove to be correct and such forward-looking statements included in
this news release should not be unduly relied upon. These
forward-looking statements speak only as of the date of this news
release. Parkland does not undertake any obligation to publicly
update or revise any forward-looking statements except as required
by securities law. Actual results could differ materially from
those anticipated in these forward-looking statements as a result
of numerous risks and uncertainties, many of which are beyond the
control of Parkland, including, but not limited to: general
economic, market and business conditions; Parkland's ability to
execute its business strategies, objectives, and initiatives,
including the completion, financing and timing thereof, realizing
the benefits therefrom, and meeting our targets and commitments
relating thereto; Parkland's ability to pay future dividends and
complete share repurchases, if any, using its NCIB program;
realization of the expected impact of the maintenance and refining
optimization work completed on the Burnaby Refinery's utilization
and profitability; Parkland's ability to execute on its asset
disposition target, including with respect to identifying buyers,
and completing such dispositions, if any, on terms reasonable to
Parkland and in a timely manner; and the assumptions and risks
described under "Cautionary Statement Regarding Forward-Looking
Information" and "Risk Factors" in Parkland's most recent Annual
Information Form, and under "Forward-Looking Information" and "Risk
Factors" in the Q1 2024 MD&A, which are incorporated by
reference herein, each as filed on SEDAR+ and available on the
Parkland website at www.parkland.ca. In addition, the 2024 Adjusted
EBITDA Guidance reflects continued integration of acquired
businesses, synergy capture, and organic growth initiatives, and
the key material assumptions include: an increase in Retail and
Commercial Fuel and petroleum product adjusted gross margin of
approximately 5 percent and Food, convenience and other adjusted
gross margin of approximately 5 percent as compared to the year
ended December 31, 2023; the
realization of $100 million of
run-rate MG&A cost efficiencies by the end of 2024; Refining
adjusted gross margin of approximately $45 to $46 per
barrel and average Burnaby Refinery composite utilization of 75
percent to 80 percent (factoring in the unplanned outage) based on
the Burnaby Refinery's crude processing capacity of 55,000 barrels
per day; enhancements to operations, utilization and optimization
of supply at the Burnaby Refinery during 2024; and implementation
of ongoing operating and MG&A cost reductions across the
business. The forward-looking statements contained in this news
release are expressly qualified by this cautionary statement.
Specified Financial Measures
This news release contains total of segments measures, non-GAAP
financial measures and non-GAAP financial ratios, supplementary
financial measures and capital management measures (collectively,
"specified financial measures"). Parkland's management uses certain
specified financial measures to analyze the operating and financial
performance, leverage, and liquidity of the business. These
specified financial measures do not have any standardized meaning
under International Financial Reporting Standards ("IFRS") and are
therefore unlikely to be comparable to similar measures presented
by other companies. The specified financial measures should not be
considered in isolation or used in substitute for measures of
performance prepared in accordance with IFRS. See Section 16 of the Q1 2024 MD&A, which is
incorporated by reference into this news release, for further
details regarding specified financial measures used by
Parkland.
Non-GAAP Financial Measures and Ratios
Adjusted earnings (loss) is a non-GAAP financial measure and
Adjusted earnings (loss) per share is a non-GAAP financial ratio,
each representing the underlying core operating performance of
business activities of Parkland at a consolidated level. The most
directly comparable financial measure to Adjusted earnings (loss)
and Adjusted earnings (loss) per share is Net earnings (loss).
Adjusted earnings (loss) and Adjusted earnings (loss) per share
represent how well Parkland's operational business is performing,
while considering depreciation and amortization, interest on leases
and long-term debt, accretion and other finance costs, and income
taxes. The Company uses these measures because it believes that
Adjusted earnings (loss) and Adjusted earnings (loss) per share are
useful for management and investors in assessing the Company's
overall performance, as they exclude certain significant items that
are not reflective of the Company's underlying business
operations.
See Section 16 of the Q1 2024
MD&A, which is incorporated by reference into this news
release, for the detailed definition and composition of Adjusted
earnings (loss).
Please see below for the reconciliation of Adjusted earnings
(loss) to net earnings (loss) and calculation of Adjusted earnings
(loss) per share.
|
Three months ended
March 31,
|
($ millions, unless otherwise
stated)
|
2024
|
2023
|
Net earnings
(loss)
|
(5)
|
77
|
Add:
|
|
|
Acquisition,
integration and other costs
|
30
|
27
|
(Gain) loss on foreign
exchange – unrealized
|
3
|
7
|
(Gain) loss on risk
management and other – unrealized
|
11
|
(32)
|
Other (gains) and
losses
|
10
|
21
|
Other adjusting
items(1)
|
10
|
21
|
Tax
normalization(2)
|
(16)
|
(7)
|
Adjusted earnings
(loss)
|
43
|
114
|
Weighted average number
of common shares (million shares)(3)
|
175
|
175
|
Weighted average number
of common shares adjusted for the effects of dilution (million
shares)(3)
|
175
|
177
|
Adjusted earnings
(loss) per share ($ per share)
|
|
|
Basic
|
0.25
|
0.65
|
Diluted
|
0.25
|
0.64
|
1
|
Other adjusting items
for the three months ended March 31, 2024 include: (i) the share of
depreciation, income taxes and other adjustments for investments in
joint ventures and associates of $4 million (2023 - $3 million);
(ii) other income of $2 million (2023 - $3 million); (iii) realized
risk management loss related to underlying physical sales activity
in another period of $3 million (2023 - $1 million loss); (iv)
adjustment to foreign exchange gains and losses related to cash
pooling arrangements of $2 million (2023 - $1 million); (v)
adjustment to realized risk management gains of $1 million related
to interest rate swaps as these gains do not relate to commodity
sale and purchase transactions (2023 - nil); and (vi) the effect of
market-based performance conditions for equity-settled share-based
award settlements of nil (2023 - $13 million).
|
|
|
2
|
The tax normalization
adjustment was applied to net earnings (loss) adjusting items that
were considered temporary differences, such as acquisition,
integration and other costs, unrealized foreign exchange gains and
losses, unrealized gains and losses on risk management and other,
gains and losses on asset disposals, changes in fair value of
redemption options, changes in estimates of environmental
provisions, loss on inventory write-downs for which there are
offsetting associated risk management derivatives with unrealized
gains, impairments of non-current assets and debt modifications.
The tax impact was estimated using the effective tax rates
applicable to jurisdictions where the related items
occur.
|
|
|
3
|
Weighted average number
of common shares is calculated in accordance with Parkland's
accounting policy contained in Note 2 of the Annual Consolidated
Financial Statements.
|
Available cash flow is a non-GAAP financial measure and
Available cash flow per share is a non-GAAP financial ratio. The
most directly comparable financial measure for Available cash flow
and Available cash flow per share is cash generated from (used in)
operating activities. Parkland uses these measures to monitor its
ability to generate cash flow for capital allocation, including
distributions to shareholders, investment in the growth of the
business, and deleveraging. Available cash flow is calculated as
cash generated from (used in) operating activities adjusted for
items such as (i) net change in (a) non-cash working capital and
(b) other assets and other liabilities, (ii) maintenance capital
expenditures, (iii) dividends received from investments in
associates and joint ventures, (iv) interest on leases and
long-term debt, and (v) payments on principal amounts on leases.
Available cash flow per share is calculated as Available cash flow
divided by the weighted average number of outstanding common
shares. See following table for a calculation of historical
Available cash flow and Available cash flow per share and a
reconciliation to cash generated from (used in) operating
activities.
|
Three months ended
|
Trailing twelve
months ended
March 31,2024
|
($ millions, unless otherwise
noted)
|
June 30,
2023(1)
|
September 30,
2023
|
December 31,
2023
|
March 31,
2024
|
Cash generated from
(used in) operating activities
|
521
|
528
|
417
|
217
|
1,683
|
Reverse: Change in
other assets and other liabilities
|
(11)
|
7
|
(4)
|
28
|
20
|
Reverse: Net change in
non-cash working capital(1)
|
(145)
|
(14)
|
17
|
63
|
(79)
|
Include: Maintenance
capital expenditures
|
(61)
|
(52)
|
(93)
|
(59)
|
(265)
|
Include: Dividends
received from investments in associates and joint
ventures
|
2
|
4
|
3
|
2
|
11
|
Include: Interest on
leases and long-term debt
|
(89)
|
(83)
|
(88)
|
(85)
|
(345)
|
Include: Payments of
principal amount on leases
|
(56)
|
(57)
|
(71)
|
(71)
|
(255)
|
Available cash
flow
|
161
|
333
|
181
|
95
|
770
|
Weighted average number
of common shares (millions)(3)
|
|
|
|
|
176
|
TTM Available cash flow
per share
|
|
|
|
|
4.38
|
|
Three months ended
|
Trailing twelve months
ended
March 31, 2023
|
($ millions, unless otherwise
noted)
|
June 30,
2022
|
September 30,
2022
|
December 31,
2022
|
March 31,
2023
|
Cash generated from
(used in) operating activities
|
341
|
404
|
629
|
314
|
1,688
|
Exclude: Adjusted
EBITDA attributable to NCI, net of tax
|
(27)
|
(11)
|
—
|
—
|
(38)
|
|
314
|
393
|
629
|
314
|
1,650
|
Reverse: Change in
other assets and other liabilities
|
(1)
|
23
|
(23)
|
11
|
10
|
Reverse: Net change in
non-cash working capital
|
88
|
(132)
|
(232)
|
18
|
(258)
|
Include: Maintenance
capital expenditures(2)
|
(44)
|
(62)
|
(118)
|
(79)
|
(303)
|
Include: Dividends
received from investments in associates and joint
ventures
|
12
|
5
|
—
|
16
|
33
|
Include: Interest on
leases and long-term debt
|
(69)
|
(76)
|
(86)
|
(92)
|
(323)
|
Exclude: Interest on
leases and long-term debt attributable to NCI
|
1
|
—
|
—
|
—
|
1
|
Include: Payments on
principal amount on leases
|
(38)
|
(50)
|
(52)
|
(51)
|
(191)
|
Exclude: Payments on
principal amount on leases attributable to NCI
|
4
|
2
|
—
|
—
|
6
|
Available cash
flow
|
267
|
103
|
118
|
137
|
625
|
Weighted average number
of common shares (millions)(3)
|
|
|
|
|
165
|
TTM Available cash flow
per share
|
|
|
|
|
3.79
|
1
|
For comparative
purposes, certain amounts within net change in non-cash working
capital for the three months ended June 30, 2023 were revised to
conform to the current period presentation.
|
|
|
2
|
For the three months
ended June 30, 2022, and September 30, 2022, and for the trailing
twelve months ended March 31, 2023, represents the amounts
attributable to Parkland.
|
|
|
3
|
Weighted average number
of common shares is calculated in accordance with Parkland's
accounting policy contained in Note 2 of the Annual Consolidated
Financial Statements.
|
The non-GAAP financial measures and ratios should not be
considered in isolation or used in substitute for measures of
performance prepared in accordance with IFRS. Except as otherwise
indicated, these non-GAAP measures and ratios are calculated and
disclosed on a consistent basis from period to period. See Section 16 of the Q1 2024 MD&A, which is
incorporated by reference into this news release, for further
details regarding Parkland's non-GAAP financial measures and
ratios.
Capital Management Measures
Parkland's primary capital management measure is the Leverage
Ratio, which is used internally by key management personnel to
monitor Parkland's overall financial strength, capital structure
flexibility, and ability to service debt and meet current and
future commitments. In order to manage its financing requirements,
Parkland may adjust capital spending or dividends paid to
shareholders, or issue new shares or new debt. The Leverage Ratio
is calculated as a ratio of Leverage Debt to Leverage EBITDA and
does not have any standardized meaning prescribed under IFRS
Accounting Standards. It is therefore unlikely to be comparable to
similar measures presented by other companies. The detailed
calculation of Leverage Ratio is as follows:
($ millions, unless otherwise
noted)
|
March 31, 2024
|
December 31, 2023
|
Leverage
Debt
|
5,208
|
4,976
|
Leverage
EBITDA
|
1,657
|
1,780
|
Leverage
Ratio
|
3.1
|
2.8
|
($ millions, unless otherwise
noted)
|
March 31, 2024
|
December 31, 2023
|
Long-term
debt
|
6,630
|
6,358
|
Less:
|
|
|
Lease
obligations
|
(1,084)
|
(1,048)
|
Cash and cash
equivalents
|
(393)
|
(387)
|
Non-recourse
debt(1)
|
(3)
|
—
|
Add:
|
|
|
Non-recourse
cash(1)
|
5
|
—
|
Letters of
credit
|
53
|
53
|
Leverage
Debt
|
5,208
|
4,976
|
|
Three months
ended
|
Trailing twelve
months
ended
March 31, 2024
|
($ millions, unless otherwise
noted)
|
June 30,
2023
|
September 30,
2023
|
December 31,
2023
|
March 31,
2024
|
Adjusted
EBITDA
|
470
|
585
|
463
|
327
|
1,845
|
Share incentive
compensation
|
6
|
5
|
11
|
6
|
28
|
Reverse: IFRS 16
impact(2)
|
(68)
|
(71)
|
(82)
|
(83)
|
(304)
|
|
408
|
519
|
392
|
250
|
1,569
|
Other
adjustments(3)
|
|
|
|
|
88
|
Leverage
EBITDA
|
|
|
|
|
1,657
|
|
Three months
ended
|
Trailing twelve
months
ended
December 31, 2023
|
($ millions, unless
otherwise noted)
|
March 31,
2023
|
June 30,
2023
|
September 30,
2023
|
December 31,
2023
|
Adjusted
EBITDA
|
395
|
470
|
585
|
463
|
1,913
|
Share incentive
compensation
|
8
|
6
|
5
|
11
|
30
|
Reverse: IFRS 16
impact(2)
|
(61)
|
(68)
|
(71)
|
(82)
|
(282)
|
|
342
|
408
|
519
|
392
|
1,661
|
Other
adjustments(3)
|
|
|
|
|
119
|
Leverage
EBITDA
|
|
|
|
|
1,780
|
(1)
|
Represents Non-recourse
debt and Non-recourse cash balances related to project
financing.
|
|
|
(2)
|
Includes the impact of
operating leases prior to the adoption of IFRS 16, previously
recognized under operating costs, which aligns with management's
view of the impact to earnings.
|
|
|
(3)
|
Includes adjustments to
normalize Adjusted EBITDA for non-recurring events including the
completion of turnarounds, the unplanned shutdown resulting from an
extreme cold weather event, a third-party power outage and the
EBITDA attributable to EV charging operations financed through
non-recourse project financing.
|
Total of Segments Measures
Adjusted EBITDA is a total of segments measure used by the chief
operating decision maker to make decisions about resource
allocation to the segment and to assess its performance. In
accordance with IFRS, adjustments and eliminations made in
preparing an entity's financial statements and allocations of
revenue, expenses, and gains or losses shall be included in
determining reported segment profit or loss only if they are
included in the measure of the segment's profit or loss that is
used by the chief operating decision maker. As such, Parkland's
Adjusted EBITDA is unlikely to be comparable to similarly named
measures presented by other issuers, who may calculate these
measures differently. Parkland views Adjusted EBITDA as the key
measure for the underlying core operating performance of business
segment activities at an operational level. Adjusted EBITDA is used
by management to set targets for Parkland (including annual
guidance and variable compensation targets) and is used to
determine Parkland's ability to service debt, finance capital
expenditures and provide for dividend payments to shareholders.
See Section 16 of the Q1 2024
MD&A, which is incorporated by reference into this news
release, for further details regarding total of segments measures
used by Parkland. Refer to the table below for the reconciliation
of Adjusted EBITDA to net earnings (loss) for the three
months ended March 31, 2024 and
March 31, 2023.
|
Three months ended
March 31,
|
($ millions)
|
2024
|
2023
|
Adjusted
EBITDA
|
327
|
395
|
Less/(add):
|
|
|
Acquisition,
integration and other costs
|
30
|
27
|
Depreciation and
amortization
|
206
|
190
|
Finance
costs
|
91
|
104
|
(Gain) loss on foreign
exchange – unrealized
|
3
|
7
|
(Gain) loss on risk
management and other – unrealized
|
11
|
(32)
|
Other (gains) and
losses(1)
|
10
|
21
|
Other adjusting
items(2)
|
10
|
21
|
Income tax expense
(recovery)
|
(29)
|
(20)
|
Net earnings
(loss)
|
(5)
|
77
|
(1)
|
Other (gains) and
losses for the three months ended March 31, 2024 include the
following: (i) $13 million non-cash valuation loss (2023 -$9
million gain) due to the change in fair value redemption options:
(ii) $5 million loss (2023 - $23 million loss) in Others,
(iii) $4 million non-cash valuation gain (2023 - $4
million loss) due to the change in estimates of environmental
provision; (iv) $2 million gain (2023 - $6 million loss) on
disposal of assets; and (v) $2 million (2023- $3 million) in Other
income. Refer to Note 12 of the Interim Condensed
Consolidated Financial Statements.
|
|
|
(2)
|
Other adjusting items
for the three months ended March 31, 2024 include: (i) the share of
depreciation, income taxes and other adjustments for investments in
joint ventures and associates of $4 million (2023 - $3 million);
(ii) other income of $2 million (2023 - $3 million); (iii) realized
risk management loss related to underlying physical sales activity
in another period of $3 million (2023 - $1 million loss); (iv)
adjustment to foreign exchange gains and losses related to cash
pooling arrangements of $2 million (2023 - $1 million); (v)
adjustment to realized risk management gains of $1 million related
to interest rate swaps as these gains do not relate to commodity
sale and purchase transactions (2023 - nil); and (vi) the effect of
market-based performance conditions for equity-settled share-based
award settlements of nil (2023 - $13 million).
|
Parkland uses Adjusted gross margin as a measure of segment
profit (loss) to analyze the performance of sale and purchase
transactions and performance on margin. The most directly
comparable financial measure is sales and operating revenue.
See Section 16 of the Q1 2024
MD&A, which is incorporated by reference into this news
release, for the detailed definition of Adjusted gross margin.
Refer to the table below for a detailed calculation of Adjusted
gross margin for the three months and three months ended
March 31, 2024 and March 31,
2023.
|
Three months ended
March 31,
|
($ millions)
|
2024
|
2023
|
Sales and operating
revenue
|
6,939
|
8,156
|
Cost of
purchases
|
(6,022)
|
(7,267)
|
Gain (loss) on risk
management and other - realized
|
(64)
|
39
|
Gain (loss) on foreign
exchange - realized
|
(8)
|
(3)
|
Other adjusting items
to Adjusted gross margin(1)
|
4
|
2
|
Adjusted gross
margin
|
849
|
927
|
Fuel and petroleum
product adjusted gross margin
|
666
|
755
|
Food, convenience and
other adjusted gross margin
|
183
|
172
|
Adjusted gross
margin
|
849
|
927
|
1
|
Includes realized risk
management loss related to underlying physical sales activity in
another period of $3 million (2023 - $1 million), adjustment to
foreign exchange gains and losses related to cash pooling
arrangements of $2 million (2023 -$1 million), and adjustment to
realized risk management gains of $1 million (2023 - nil) related
to interest rate swaps as these gains do not relate to the
commodity sale and purchase transactions.
|
Supplementary Financial Measures
Parkland uses a number of supplementary financial measures,
including Adjusted EBITDA Guidance, Leverage Ratio Guidance, TTM
Cash generated from (used in) operating activities, and TTM Cash
generated from (used in) operating activities per share, and these
measures may not be comparable to similar measures presented by
other issuers, as other issuers may calculate these measures
differently. See Section 16 of
the Q1 2024 MD&A, which is incorporated by reference into this
news release, for further details regarding supplementary financial
measures used by Parkland, including the composition of such
measures.
Non-Financial Measures
Parkland uses a number of non-financial measures, including
Company SSVG, composite utilization and total recordable injury
frequency rate, in measuring the success of our strategic
objectives and to set variable compensation targets for employees.
These non-financial measures are not accounting measures, do not
have comparable IFRS measures, and may not be comparable to similar
measures presented by other issuers, as other issuers may calculate
these metrics differently. See
Section 16 of the Q1 2024 MD&A, which is incorporated by
reference into this news release, for further details on the
non-financial measures used by Parkland.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/parkland-reports-2024-first-quarter-results-302133703.html
SOURCE Parkland Corporation